by Instem Team | Jan 14, 2025 | Resources
Let’s re-imagine the carcinogenicity assessment In the fast-paced and cost-conscious ‘drug to market’ race, momentum can be gained by implementing a Weight of Evidence (WoE) to negate unnecessary preclinical testing. We will present results from a...
by Lara Wilkinson | Dec 16, 2024 | Resources
Gain insight into the growing prominence of Weight of Evidence approaches in safety assessments and learn specifically how SEND datasets can facilitate the incorporation of relevant preclinical data into specific factors.
